Clinical utility evaluation paradigm
Background: Foundation models for clinical prediction must eventually bridge the gap between algorithmic next-event forecasting and actionable clinical support. Traditional discrimination metrics often fail to capture the real-world impact or integration challenges of deploying these systems.
Question / Future Work: Research is required to establish new evaluation paradigms that measure the actionable clinical utility of generative disease trajectory models, moving beyond standard AUC metrics to assess impact on clinical decision-making or health system forecasting.
Why It Matters: Transitioning from predictive discriminative performance to actionable clinical utility is a fundamental challenge for the long-term viability of clinical foundation models.
Metadata & Links
- created_at
- 2026-05-17T06:08:44Z